Effects of beta-carotene and alpha-tocopherol on bleomycin-induced chromosomal damage.

The number of bleomycin-induced chromosomal breaks in cultured peripheral blood lymphocytes has been proposed as a measure of the sensitivity of an individual to carcinogens. Although "mutagen sensitivity" (clastogenicity) may be a useful biomarker for the identification of individuals at high risk for DNA damage, there is some uncertainty whether the results of this assay can be modified by environmental factors, such as diet. We designed an intervention study to determine whether micronutrient supplementation with beta-carotene and alpha-tocopherol influenced the mutagenicity score among 22 healthy volunteers. This intervention study followed a double-blind, randomized, cross-over design. Chromatid breaks ranged from 0.30 to 2.30 per cell and were uncorrelated with plasma beta-carotene (r = -0.07; P = 0.50) and a-tocopherol (r = -0.01; P = 0.92) levels, after accounting for the time of the measurement. The average number of breaks per cell was similar (P for difference in means = 0.90) among subjects during periods of vitamin supplementation (mean = 0.87 breaks per cell) and placebo (mean = 0.86 breaks per cell), averaged over groups and after adjustment for baseline breaks. Substantial within-person variation may indicate some imprecision in the mutagen sensitivity assessment. Our results suggest that mutagen sensitivity is not affected by plasma levels of beta-carotene or alpha-tocopherol. Although mutagen sensitivity does not appear to be modified by changes in plasma levels of two common antioxidant vitamins, it may be useful for the identification of high-risk individuals for participation in large intervention studies with cancer outcomes.

[1]  T. Hsu Genetic instability in the human population: a working hypothesis. , 2008, Hereditas.

[2]  H. Tobi,et al.  Lack of effect of daily N-acetylcysteine supplementation on mutagen sensitivity. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[3]  M. Spitz,et al.  A statistical analysis of the reliability and classification error in application of the mutagen sensitivity assay. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[4]  L. Marchand,et al.  Correlations between mutagen sensitivity and plasma nutrient levels of healthy individuals. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[5]  M. Spitz,et al.  Mutagen sensitivity as a risk factor for second malignant tumors following malignancies of the upper aerodigestive tract. , 1994, Journal of the National Cancer Institute.

[6]  K. Olden,et al.  Mutagen hypersensitivity as a biomarker of genetic predisposition to carcinogenesis. , 1994, Journal of the National Cancer Institute.

[7]  G. Snow,et al.  Association between bleomycin genotoxicity and non-constitutional risk factors for head and neck cancer. , 1993, Cancer letters.

[8]  M. Spitz,et al.  Mutagen sensitivity in upper aerodigestive tract cancer: a case-control analysis. , 1993, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[9]  M. Spitz,et al.  Mutagen sensitivity: a biological marker of cancer susceptibility. , 1991, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[10]  J. Reidy,et al.  Vitamin C intake influences the bleomycin-induced chromosome damage assay: implications for detection of cancer susceptibility and chromosome breakage syndromes. , 1989, Mutation research.

[11]  B. Dunn,et al.  Relationship between cellular levels of beta‐carotene and sensitivity to genotoxic agents , 1986, International journal of cancer.

[12]  D. E. Johnson,et al.  Analysis of Messy Data Volume I: Designed Experiments , 1985 .

[13]  S. Weitzman,et al.  Effects of antioxidants on oxidant-induced sister chromatid exchange formation. , 1985, The Journal of clinical investigation.

[14]  M. Spitz,et al.  In vitro protective effects of chemopreventive agents against bleomycin-induced genotoxicity in lymphoblastoid cell lines and peripheral blood lymphocytes of head and neck cancer patients. , 1993, Cancer detection and prevention.